Current status of contemporary diagnostic radiotracers in the management of breast cancer: first steps toward theranostic applications

ConclusionImaging of treatment targets with PET tracers may provide a more reliable precision medicine tool to find the right treatment for the right patient at the right time. In addition to visualization of the target of treatment, theranostic trials with alpha- or beta-emitting isotopes provide a future treatment option for patients with metastatic breast cancer.
Source: EJNMMI Research - Category: Radiology Source Type: research